Research article Special Issues

Identification and verification of FN1, P4HA1 and CREBBP as potential biomarkers in human atrial fibrillation


  • Received: 06 November 2022 Revised: 18 January 2023 Accepted: 26 January 2023 Published: 08 February 2023
  • Background 

    Atrial fibrillation (AF) is a common arrhythmia that can lead to cardiac complications. The mechanisms involved in AF remain elusive. We aimed to explore the potential biomarkers and mechanisms underpinning AF.

    Methods 

    An independent dataset, GSE2240, was obtained from the Gene Expression Omnibus database. The R package, "limma", was used to screen for differentially expressed genes (DEGs) in individuals with AF and normal sinus rhythm (SR). Weighted gene co-expression network analysis (WGCNA) was applied to cluster DEGs into different modules based on functional disparities. Enrichment analyses were performed using the Database for Annotation, Visualization and Integrated Discovery. A protein–protein interaction network was constructed, and hub genes were identified using cytoHubba. Quantitative reverse-transcription PCR was used to validate mRNA expression in individuals with AF and SR.

    Results 

    We identified 2, 589 DEGs clustered into 10 modules using WGCNA. Gene Ontology analysis showed specific clustered genes significantly enriched in pathways associated with the extracellular matrix and collagen organization. Kyoto Encyclopedia of Genes and Genomes pathway analysis revealed that the target genes were mainly enriched for proteoglycans in cancer, extracellular matrix–receptor interaction, focal adhesion, and the PI3K-Akt signaling pathway. Three hub genes, FN1, P4HA1 and CREBBP, were identified, which were highly correlated with AF endogenesis. mRNA expression of hub genes in patients with AF were higher than in individuals with normal SR, consistent with the results of bioinformatics analysis.

    Conclusions 

    FN1, P4HA1, and CREBBP may play critical roles in AF. Using bioinformatics, we found that expression of these genes was significantly elevated in patients with AF than in individuals with normal SR. Furthermore, these genes were elevated at core positions in the mRNA interaction network. These genes should be further explored as novel biomarkers and target candidates for AF therapy.

    Citation: Miao Zhu, Tao Yan, Shijie Zhu, Fan Weng, Kai Zhu, Chunsheng Wang, Changfa Guo. Identification and verification of FN1, P4HA1 and CREBBP as potential biomarkers in human atrial fibrillation[J]. Mathematical Biosciences and Engineering, 2023, 20(4): 6947-6965. doi: 10.3934/mbe.2023300

    Related Papers:

    [1] Ruiping Yuan, Jiangtao Dou, Juntao Li, Wei Wang, Yingfan Jiang . Multi-robot task allocation in e-commerce RMFS based on deep reinforcement learning. Mathematical Biosciences and Engineering, 2023, 20(2): 1903-1918. doi: 10.3934/mbe.2023087
    [2] Yangjie Sun, Xiaoxi Che, Nan Zhang . 3D human pose detection using nano sensor and multi-agent deep reinforcement learning. Mathematical Biosciences and Engineering, 2023, 20(3): 4970-4987. doi: 10.3934/mbe.2023230
    [3] Jin Zhang, Nan Ma, Zhixuan Wu, Cheng Wang, Yongqiang Yao . Intelligent control of self-driving vehicles based on adaptive sampling supervised actor-critic and human driving experience. Mathematical Biosciences and Engineering, 2024, 21(5): 6077-6096. doi: 10.3934/mbe.2024267
    [4] Siqi Chen, Ran Su . An autonomous agent for negotiation with multiple communication channels using parametrized deep Q-network. Mathematical Biosciences and Engineering, 2022, 19(8): 7933-7951. doi: 10.3934/mbe.2022371
    [5] Shixuan Yao, Xiaochen Liu, Yinghui Zhang, Ze Cui . An approach to solving optimal control problems of nonlinear systems by introducing detail-reward mechanism in deep reinforcement learning. Mathematical Biosciences and Engineering, 2022, 19(9): 9258-9290. doi: 10.3934/mbe.2022430
    [6] Siqi Chen, Yang Yang, Ran Su . Deep reinforcement learning with emergent communication for coalitional negotiation games. Mathematical Biosciences and Engineering, 2022, 19(5): 4592-4609. doi: 10.3934/mbe.2022212
    [7] Jia Mian Tan, Haoran Liao, Wei Liu, Changjun Fan, Jincai Huang, Zhong Liu, Junchi Yan . Hyperparameter optimization: Classics, acceleration, online, multi-objective, and tools. Mathematical Biosciences and Engineering, 2024, 21(6): 6289-6335. doi: 10.3934/mbe.2024275
    [8] Jingxu Xiao, Chaowen Chang, Yingying Ma, Chenli Yang, Lu Yuan . Secure multi-path routing for Internet of Things based on trust evaluation. Mathematical Biosciences and Engineering, 2024, 21(2): 3335-3363. doi: 10.3934/mbe.2024148
    [9] Koji Oshima, Daisuke Yamamoto, Atsuhiro Yumoto, Song-Ju Kim, Yusuke Ito, Mikio Hasegawa . Online machine learning algorithms to optimize performances of complex wireless communication systems. Mathematical Biosciences and Engineering, 2022, 19(2): 2056-2094. doi: 10.3934/mbe.2022097
    [10] Jose Guadalupe Beltran-Hernandez, Jose Ruiz-Pinales, Pedro Lopez-Rodriguez, Jose Luis Lopez-Ramirez, Juan Gabriel Avina-Cervantes . Multi-Stroke handwriting character recognition based on sEMG using convolutional-recurrent neural networks. Mathematical Biosciences and Engineering, 2020, 17(5): 5432-5448. doi: 10.3934/mbe.2020293
  • Background 

    Atrial fibrillation (AF) is a common arrhythmia that can lead to cardiac complications. The mechanisms involved in AF remain elusive. We aimed to explore the potential biomarkers and mechanisms underpinning AF.

    Methods 

    An independent dataset, GSE2240, was obtained from the Gene Expression Omnibus database. The R package, "limma", was used to screen for differentially expressed genes (DEGs) in individuals with AF and normal sinus rhythm (SR). Weighted gene co-expression network analysis (WGCNA) was applied to cluster DEGs into different modules based on functional disparities. Enrichment analyses were performed using the Database for Annotation, Visualization and Integrated Discovery. A protein–protein interaction network was constructed, and hub genes were identified using cytoHubba. Quantitative reverse-transcription PCR was used to validate mRNA expression in individuals with AF and SR.

    Results 

    We identified 2, 589 DEGs clustered into 10 modules using WGCNA. Gene Ontology analysis showed specific clustered genes significantly enriched in pathways associated with the extracellular matrix and collagen organization. Kyoto Encyclopedia of Genes and Genomes pathway analysis revealed that the target genes were mainly enriched for proteoglycans in cancer, extracellular matrix–receptor interaction, focal adhesion, and the PI3K-Akt signaling pathway. Three hub genes, FN1, P4HA1 and CREBBP, were identified, which were highly correlated with AF endogenesis. mRNA expression of hub genes in patients with AF were higher than in individuals with normal SR, consistent with the results of bioinformatics analysis.

    Conclusions 

    FN1, P4HA1, and CREBBP may play critical roles in AF. Using bioinformatics, we found that expression of these genes was significantly elevated in patients with AF than in individuals with normal SR. Furthermore, these genes were elevated at core positions in the mRNA interaction network. These genes should be further explored as novel biomarkers and target candidates for AF therapy.



    Let C be the complex plane. Denote by CN the N-dimensional complex Euclidean space with the inner product z,w=Nj=1zj¯wj; by |z|2=z,z; by H(CN) the set of all holomorphic functions on CN; and by I the identity operator on CN.

    The Fock space F2(CN) is a Hilbert space of all holomorphic functions fH(CN) with the inner product

    f,g=1(2π)NCNf(z)¯g(z)e12|z|2dν(z),

    where ν(z) denotes Lebesgue measure on CN. To simplify notation, we will often use F2 instead of F2(CN), and we will denote by f the corresponding norm of f. The reproducing kernel functions of the Fock space are given by

    Kw(z)=ez,w2,zCN,

    which means that if fF2, then f(z)=f,Kz for all zCN. It is easy to see that Kw=e|w|2/4. Therefore, the following evaluation holds:

    |f(z)|e|z|24f

    for fF2 and zCN. If kw is the normalization of Kw, then

    kw(z)=ez,w2|w|24,zCN.

    Indeed, F2 is used to describe systems with varying numbers of particles in the states of quantum harmonic oscillators. On the other hand, the reproducing kernels in F2 are used to describe the coherent states in quantum physics. See [17] for more about the Fock space, and see [1,7,11] for the studies of some operators on the Fock space.

    For a given holomorphic mapping φ:CNCN and uH(CN), the weighted composition operator, usually denoted by Wu,φ, on or between some subspaces of H(CN) is defined by

    Wu,φf(z)=u(z)f(φ(z)).

    When u=1, it is the composition operator, usually denoted by Cφ. While φ(z)=z, it is the multiplication operator, usually denoted by Mu.

    Forelli in [8] proved that the isometries on Hardy space Hp defined on the open unit disk (for p2) are certain weighted composition operators, which can be regarded as the earliest presence of the weighted composition operators. Weighted composition operators have also been used in descriptions of adjoints of composition operators (see [4]). An elementary problem is to provide function-theoretic characterizations for which the symbols u and φ induce a bounded or compact weighted composition operator on various holomorphic function spaces. There have been many studies of the weighted composition operators and composition operators on holomorphic function spaces. For instance, several authors have recently worked on the composition operators and weighted composition operators on Fock space. For the one-variable case, Ueki [13] characterized the boundedness and compactness of weighted composition operators on Fock space. As a further work of [13], Le [10] found the easier criteria for the boundedness and compactness of weighted composition operators. Recently, Bhuia in [2] characterized a class of C-normal weighted composition operators on Fock space.

    For the several-variable case, Carswell et al. [3] studied the boundedness and compactness of composition operators. From [3], we see that the one-variable case composition operator Cφ is bounded on Fock space if and only if φ(z)=az+b, where |a|1, and if |a|=1, then b=0. Let A:CNCN be a linear operator. Zhao [14,15,16] characterized the unitary, invertible, and normal weighted composition operator Wu,φ on Fock space, when φ(z)=Az+b and u=kc. Interestingly enough, Zhao [15] proved that for φ(z)=Az+b and u(z)=Kc(z), weighted composition operator Wu,φ is bounded on Fock space if and only if A1 and Aζ,b+Ac=0 whenever |Aζ|=|ζ| for ζCN.

    Motivated by the above-mentioned interesting works, for the special symbols φ(z)=Az+b and u=Kc, here we study the adjoint, self-adjointness, and hyponormality of weighted composition operators on Fock space. Such properties of the abstract or concrete operators (for example, Toeplitz operators, Hankel operators, and composition operators) have been extensively studied on some other holomorphic function spaces. This paper can be regarded as a continuation of the weighted composition operators on Fock space.

    In this section, we characterize the adjoints of weighted composition operators Wu,φ on Fock space, where φ(z)=Az+b and u=Kc.

    We first have the following result:

    Lemma 2.1. Let A, B:CNCN be linear operators with A1 and B1, φ(z)=Az+a, ψ(z)=Bz+b for a,bCN, and the operators Cφ and Cψ be bounded on F2. Then

    CφCψ=WKa,BAz+b,

    where A is the adjoint operator of A.

    Proof. From Lemma 2 in [3], it follows that

    CφCψ=MKaCAzCBz+b=MKaC(Bz+b)Az=MKaCBAz+b=WKa,BAz+b,

    from which the result follows. The proof is complete.

    In Lemma 2.1, we prove that the product of the adjoint of a composition operator and another composition operator is expressed as a weighted composition operator. Next, we will see that in some sense, the converse of Lemma 2.1 is also true. Namely, we will prove that if φ(z)=Az+b, where A:CNCN is a linear operator with A<1, and u=Kc, then the operator Wu,φ on F2 can be written as the product of the adjoint of a composition operator and another composition operator.

    Lemma 2.2. Let A:CNCN be a linear operator with A<1. If A and c satisfy the condition Aζ,c=0 whenever |Aζ|=|ζ|, then there exists a positive integer n such that the operator Wu,φ on F2 defined by φ(z)=Az+b and u(z)=Kc(z) is expressed as

    Wu,φ=Cn+1nAz+cCnn+1z+b.

    Proof. From Theorem 2 in [3], we see that the operator CAz+c is bounded on F2. Since A<1, there exists a large enough positive integer n such that

    (1+1n)A1.

    Also, by Theorem 2 in [3], the operator Cn+1nAz+c is bounded on F2, which implies that the operator Cn+1nAz+c is also bounded on F2. Since |nn+1Iζ|=|ζ| if and only if ζ=0, nn+1Iζ,b=0 whenever |nn+1Iζ|=|ζ|. By Theorem 2 in [3], the operator Cnn+1Iz+b is bounded on F2. Then, it follows from Lemma 2.1 that

    Cn+1nAz+cCnn+1Iz+b=WKc,Az+b.

    The proof is complete.

    Now, we can obtain the adjoint for some weighted composition operators.

    Theorem 2.1. Let φ(z)=Az+b, u(z)=Kc(z), and A and c satisfy Aζ,c=0 whenever |Aζ|=|ζ|. Then it holds that

    Wu,φ=WKb,Az+c.

    Proof. In Lemma 2.2, we have

    Wu,φ=Cn+1nAz+cCnn+1Iz+b. (2.1)

    It follows from (2.1) that

    Wu,φ=Cnn+1Iz+bCn+1nAz+c. (2.2)

    Therefore, from (2.2) and Lemma 2.1, the desired result follows. The proof is complete.

    By using the kernel functions, we can obtain the following result:

    Lemma 2.3. Let the operator Wu,φ be a bounded operator on F2. Then it holds that

    Wu,φKw=¯u(w)Kφ(w).

    Proof. Let f be an arbitrary function in F2. We see that

    Wu,φKw,f=Kw,Wu,φf=¯Wu,φf,Kw=¯u(w)f(φ(w))=¯u(w)Kφ(w),f.

    From this, we deduce that Wu,φKw=¯u(w)Kφ(w). The proof is complete.

    Here, we characterize the self-adjoint weighted composition operators.

    Theorem 2.2. Let A:CNCN be a linear operator, b,cCN, φ(z)=Az+b, u(z)=Kc(z), and the operator Wu,φ be bounded on F2. Then the operator Wu,φ is self-adjoint on F2 if and only if A:CNCN is self-adjoint and b=c.

    Proof. In Lemma 2.3, we have

    Wu,φKw(z)=¯u(w)Kφ(w)=¯Kc(w)ez,φ(w)2=ec,w2ez,Aw+b2. (2.3)

    On the other hand,

    Wu,φKw(z)=u(z)Kw(φ(z))=ez,c2eAz+b,w2. (2.4)

    It is clear that operator Wu,φ is self-adjoint on F2 if and only if

    Wu,φKw=Wu,φKw.

    From (2.3) and (2.4), it follows that

    ec,w2ez,Aw+b2=ez,c2eAz+b,w2. (2.5)

    Letting z=0 in (2.5), we obtain that ec,w2=eb,w2 which implies that

    c,wb,w=4kπi, (2.6)

    where kN. Also, letting w=0 in (2.6), we see that k=0. This shows that c,wb,w=0, that is, c,w=b,w. From this, we deduce that b=c. Therefore, (2.5) becomes ez,Aw2=eAz,w2. From this, we obtain that z,Aw=Az,w, which implies that Az,w=Az,w. This shows that A=A, that is, A:CNCN is self-adjoint.

    Now, assume that A is a self-adjoint operator on CN and b=c. A direct calculation shows that (2.5) holds. Then Wu,φ is a self-adjoint operator on F2. The proof is complete.

    In [14], Zhao proved that the operator Wu,φ on F2 is unitary if and only if there exist an unitary operator A:CNCN, a vector bCN, and a constant α with |α|=1 such that φ(z)=Azb and u(z)=αKA1b(z). Without loss of generality, here we characterize the self-adjoint unitary operator Wu,φ on F2 for the case α=1 and obtain the following result from Theorem 2.2.

    Corollary 2.1. Let A:CNCN be a unitary operator and bCN such that φ(z)=Azb and u(z)=KA1b(z). Then the operator Wu,φ is self-adjoint on F2 if and only if A:CNCN is self-adjoint and Ab+b=0.

    First, we recall the definition of hyponormal operators. An operator T on a Hilbert space H is said to be hyponormal if AxAx for all vectors xH. T is called co-hyponormal if T is hyponormal. In 1950, Halmos, in his attempt to solve the invariant subspace problem, extended the notion of normal operators to two new classes, one of which is now known as the hyponormal operator (see [9]). Clearly, every normal operator is hyponormal. From the proof in [6], it follows that T is hyponormal if and only if there exists a linear operator C with C1 such that T=CT. In some sense, this result can help people realize the characterizations of the hyponormality of some operators. For example, Sadraoui in [12] used this result to characterize the hyponormality of composition operators defined by the linear fractional symbols on Hardy space. On the other hand, some scholars studied the hyponormality of composition operators on Hardy space by using the fact that the operator Cφ on Hardy space is hyponormal if and only if

    Cφf2Cφf2

    for all f in Hardy space. For example, Dennis in [5] used the fact to study the hyponormality of composition operators on Hardy space. In particular, this inequality for norms is used when f is a reproducing kernel function Kw for any wCN. Actually, to the best of our knowledge, there are few studies on the hyponormality of weighted composition operators. Here, we consider this property of weighted composition operators on Fock space.

    First, we have the following result, which can be proved by using the reproducing kernel functions.

    Lemma 3.1. Let wCN and the operator Wu,φ be bounded on F2. Then

    Wu,φKw2=Wu,φWu,φKw(w).

    Proof. From the inner product, we have

    Wu,φKw2=Wu,φKw,Wu,φKw=Wu,φWu,φKw,Kw=Wu,φWu,φKw(w).

    The proof is complete.

    Theorem 3.1. Let A:CNCN be a linear operator, φ(z)=Az+b, u=kc, and the operator Wu,φ be bounded on F2. If the operator Wu,φ is hyponormal on F2, then Abb=Acc and |b||c|.

    Proof. From a direct calculation, we have

    Wu,φKw(z)=u(z)Kw(φ(z))=kc(z)Kw(Az+b)=ez,c2|c|24eAz+b,w2=ez,Aw+c+b,w2|c|24=eb,w2|c|24KAw+c(z). (3.1)

    From (3.1), it follows that

    Wu,φWu,φKw(z)=eb,w2|c|24Wu,φKAw+c(z)=eb,w2|c|24¯u(Aw+c)Kφ(Aw+c)(z)=eb,w2+c,Aw+c2+z,AAw+Ac+b2|c|22=eb+Ac,w2+z,AAw2+z,Ac+b2. (3.2)

    On the other hand, we also have

    Wu,φWu,φKw(z)=¯u(w)Wu,φKφ(w)(z)=¯u(w)u(z)Kφ(w)(φ(z))=ec,w2+z,c2+Az+b,Aw+b2|c|22=ec+Ab,w2+|b|22+z,AAw2+z,c+Ab2|c|22. (3.3)

    From Lemma 3.1, (3.2), and (3.3), it follows that

    Wu,φKw2=Wu,φWu,φKw(w)=ec+Ab,w2+|b|22+|Aw|22+w,c+Ab2|c|22

    and

    Wu,φKw2=Wu,φWu,φKw(w)=eb+Ac,w2+|Aw|22+w,Ac+b2.

    Then, we have

    Wu,φKw2Wu,φKw2=e|Aw|22(ec+Ab,w2+|b|22+w,c+Ab2|c|22eb+Ac,w2+w,Ac+b2),

    which shows that

    Wu,φKw2Wu,φKw20

    for all wCN if and only if

    ec+Ab,w2+|b|22+w,c+Ab2|c|22eb+Ac,w2+w,Ac+b2. (3.4)

    It is clear that (3.4) holds if and only if

    c+Ab,w+|b|2+w,c+Ab|c|2b+Ac,w+w,Ac+b. (3.5)

    From (3.5), we see that (3.4) holds if and only if

    AbAc+cb,w+w,AbAc+cb+|b|2|c|20. (3.6)

    Therefore, we deduce that (3.4) holds for all wCN if and only if |b||c| and Abb=Acc. The proof is complete.

    If b=c=0 in Theorem 3.1, then Wu,φ is reduced into the composition operator CAz. For this case, Theorem 3.1 does not provide any useful information on the operator A:CNCN when CAz is hyponormal on F2. However, we have the following result, which completely characterizes the hyponormal composition operators:

    Theorem 3.2. Let A:CNCN be a linear operator such that CAz is bounded on F2. Then the operator CAz is hyponormal on F2 if and only if A:CNCN is co-hyponormal.

    Proof. Assume that A:CNCN is co-hyponormal. Then there exists an operator B:CNCN with B1 such that A=BA. We therefore have

    CAz=CAz=CABz=CBzCAz.

    Next, we want to show that CBz=1. By Theorem 4 in [3], we have

    CBz=e14(|w0|2|Bw0|2), (3.7)

    where w0 is any solution to (IBB)w=0. From this, we obtain that w0=BBw0, and then

    |Bw0|2=Bw0,Bw0=w0,BBw0=w0,w0=|w0|2. (3.8)

    Thus, by considering (3.7) and (3.8), we see that CBz=1. It follows that the operator CAz is hyponormal on F2.

    Now, assume that the operator CAz is hyponormal on F2. Then there exists a linear operator C on F2 with C1 such that CAz=CCAz. By Lemma 2 in [3], we have CAz=CAz. This shows that CCAz is a composition operator. This result shows that there exists a holomorphic mapping φ:CNCN such that C=Cφ. So Az=A(φ(z)) for all zCN, which implies that there exists a linear operator B:CNCN such that φ(z)=Bz, and then C=CBz. Therefore, A=AB, that is, A=BA. Since C1, this shows that the operator C=CBz is bounded on F2. From Lemma 2.3 in [15], we obtain that B1, which also shows that B1 since B=B. We prove that A:CNCN is co-hyponormal. The proof is complete.

    Remark 3.1. In the paper, we only obtain a necessary condition for the hyponormality of weighted composition operators on Fock space. We hope that the readers can continuously consider the problem in Fock space.

    In this paper, I give a proper description of the adjoint Wu,φ on Fock space for the special symbol functions u(z)=Kc(z) and φ(z)=Az+b. However, it is difficult to give a proper description of the general symbols. On the other hand, I consider the hyponormal weighted composition operators on Fock space and completely characterize hyponormal composition operators on this space. I hope that people are interested in the research in this paper.

    The authors declare they have not used Artificial Intelligence (AI) tools in the creation of this article.

    This study was supported by Sichuan Science and Technology Program (2024NSFSC0416).

    The author declares that he has no competing interests.



    [1] C. T. January, L. S. Wann, J. S. Alpert, H. Calkins, J. E. Cigarroa, J. C. ClevelandJr, et al., 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society, J. Am. Coll. Cardiol., 130 (2014), e199–e267. https://doi.org/10.1161/CIR.0000000000000041 doi: 10.1161/CIR.0000000000000041
    [2] S. S. Chugh, R. Havmoeller, K. Narayanan, D. Singh, M. Rienstra, E. J. Benjamin, et al., Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study, Circulation, 129 (2014), 837-847. https://doi.org/10.1161/CIRCULATIONAHA.113.005119 doi: 10.1161/CIRCULATIONAHA.113.005119
    [3] R. S. Wijesurendra, B. Casadei, Mechanisms of atrial fibrillation, Heart, 105 (2019), 1860-1867. https://doi.org/10.1136/heartjnl-2018-314267 doi: 10.1136/heartjnl-2018-314267
    [4] S. Jame, G. Barnes, Stroke and thromboembolism prevention in atrial fibrillation, Heart, 106 (2020), 10-17. https://doi.org/10.1136/heartjnl-2019-314898 doi: 10.1136/heartjnl-2019-314898
    [5] C. C. Wang, C. L. Lin, G. J. Wang, C. T. Chang, F. C. Sung, C. H. Kao, Atrial fibrillation associated with increased risk of venous thromboembolism-A population-based cohort study, Thromb. Haemost., 113 (2015), 185-192. https://doi.org/10.1160/TH14-05-0405 doi: 10.1160/TH14-05-0405
    [6] E. J. Benjamin, P. A. Wolf, R. B. D'Agostino, H. Silbershatz, W. B. Kannel, D. Levy, Impact of atrial fibrillation on the risk of death: the Framingham Heart Study, Circulation, 98 (1998), 946-952. https://doi.org/10.1161/01.CIR.98.10.946 doi: 10.1161/01.CIR.98.10.946
    [7] T. J. Wang, M. G. Larson, D. Levy, E. J. Benjamin, E. P. Leip, T. Omland, et al., Plasma natriuretic peptide levels and the risk of cardiovascular events and death, N. Engl. J. Med., 350 (2004), 655-663. https://doi.org/10.1056/NEJMoa031994 doi: 10.1056/NEJMoa031994
    [8] R. B. Schnabel, M. G. Larson, J. F. Yamamoto, L. M. Sullivan, M. J. Pencina, J. B. Meigs, et al., Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community, Circulation, 121 (2010), 200-207. https://doi.org/10.1161/CIRCULATIONAHA.109.882241 doi: 10.1161/CIRCULATIONAHA.109.882241
    [9] K. K. Patton, P. T. Ellinor, S. R. Heckbert, R. H. Christenson, C. DeFilippi, J. S. Gottdiener, et al., N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study, Circulation, 120 (2009), 1768-1774. https://doi.org/10.1161/CIRCULATIONAHA.109.873265 doi: 10.1161/CIRCULATIONAHA.109.873265
    [10] R. J. Aviles, D. O. Martin, C. Apperson-Hansen, P. L. Houghtaling, P. Rautaharju, R. A. Kronmal, et al., Inflammation as a risk factor for atrial fibrillation, Circulation, 108 (2003), 3006-3010. https://doi.org/10.1161/01.CIR.0000103131.70301.4F doi: 10.1161/01.CIR.0000103131.70301.4F
    [11] K. W. Lee, T. H. EverettIV, D. Rahmutula, J. M. Guerra, E. Wilson, C. Ding, et al., Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure, Circulation, 114 (2006), 1703-1712. https://doi.org/10.1161/CIRCULATIONAHA.106.624320 doi: 10.1161/CIRCULATIONAHA.106.624320
    [12] M. Rienstra, X. Yin, M. G. Larson, J. D. Fontes, J. W. Magnani, D. D. McManus, et al., Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I and incident atrial fibrillation, Am. Heart J., 167 (2014) 109-115. https://doi.org/10.1016/j.ahj.2013.10.003 doi: 10.1016/j.ahj.2013.10.003
    [13] Y. Nakano, S. Niida, K. Dote, S. Takenaka, H. Hirao, F. Miura, et al., Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation, J. Am. Coll. Cardiol., 43 (2004), 818-825. https://doi.org/10.1016/j.jacc.2003.08.060 doi: 10.1016/j.jacc.2003.08.060
    [14] F. Gramley, J. Lorenzen, E. Koellensperger, K. Kettering, C. Weiss, T. Munzel, Atrial fibrosis and atrial fibrillation: the role of the TGF-beta1 signaling pathway, Int. J. Cardiol., 143 (2010), 405-413. https://doi.org/10.1016/j.ijcard.2009.03.110 doi: 10.1016/j.ijcard.2009.03.110
    [15] M. E. Ritchie, B. Phipson, D. Wu, Y. Hu, C. W. Law, W. Shi, et al., limma powers differential expression analyses for RNA-sequencing and microarray studies, Nucleic Acids Res., 43 (2015), e47. https://doi.org/10.1093/nar/gkv007 doi: 10.1093/nar/gkv007
    [16] B. Zhang, S. Horvath, A general framework for weighted gene co-expression network analysis, Stat. Appl. Genet. Mol. Biol., 4 (2005). https://doi.org/10.2202/1544-6115.1128 doi: 10.2202/1544-6115.1128
    [17] D. W. Huang, B. T. Sherman, R. A. Lempicki, Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists, Nucleic Acids Res., 37 (2009), 1-13. https://doi.org/10.1093/nar/gkn923 doi: 10.1093/nar/gkn923
    [18] A. Subramanian, P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert, M. A. Gillette, et al., Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc. Natl. Acad. Sci. U. S. A., 102 (2005), 15545-15550. https://doi.org/10.1073/pnas.0506580102 doi: 10.1073/pnas.0506580102
    [19] D. Szklarczyk, A. L. Gable, D. Lyon, A. Junge, S. Wyder, J. Huerta-Cepas, et al., STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets, Nucleic Acids Res., 47 (2019), D607-D613. https://doi.org/10.1093/nar/gky1131 doi: 10.1093/nar/gky1131
    [20] P. Shannon, A. Markiel, O. Ozier, N. S. Baliga, J. T. Wang, D. Ramage, et al., Cytoscape: a software environment for integrated models of biomolecular interaction networks, Genome Res., 13 (2003), 2498-2504. https://doi.org/10.1101/gr.1239303 doi: 10.1101/gr.1239303
    [21] C. H. Chin, S. H. Chen, H. H. Wu, C. W. Ho, M. T. Ko, C. Y. Lin, cytoHubba: identifying hub objects and sub-networks from complex interactome, BMC Syst. Biol., 8 (2014). https://doi.org/10.1186/1752-0509-8-S4-S11 doi: 10.1186/1752-0509-8-S4-S11
    [22] G. Yu, L. G. Wang, Y. Han, Q. Y. He, clusterProfiler: an R package for comparing biological themes among gene clusters, OMICS, 16 (2012), 284-287. https://doi.org/10.1089/omi.2011.0118 doi: 10.1089/omi.2011.0118
    [23] S. S. Virani, A. Alonso, E. J. Benjamin, M. S. Bittencourt, C. W. Callaway, A. P. Carson, et al., Heart disease and stroke statistics-2020 update: a report from the American heart association, Circulation, 141 (2020), e139-e596. https://doi.org/10.1161/CIR.0000000000000757 doi: 10.1161/CIR.0000000000000757
    [24] M. Böhm, M. D. Ezekowitz, S. J. Connolly, J. W. Eikelboom, S. H. Hohnloser, P. A. Reilly, et al., Changes in renal function in patients with atrial fibrillation: an analysis from the RE-LY trial, J. Am. Coll. Cardiol., 65 (2015), 2481-2493. https://doi.org/10.1016/j.jacc.2015.03.577 doi: 10.1016/j.jacc.2015.03.577
    [25] E. Z. Soliman, M. M. Safford, P. Muntner, Y. Khodneva, F. Z. Dawood, N. A. Zakai, et al., Atrial fibrillation and the risk of myocardial infarction, JAMA Intern. Med., 174 (2014), 107-114. https://doi.org/10.1001/jamainternmed.2013.11912 doi: 10.1001/jamainternmed.2013.11912
    [26] D. P. Morin, M. L. Bernard, C. Madias, P. A. Rogers, S. Thihalolipavan, N. A. M. Estes III, The state of the art: atrial fibrillation epidemiology, prevention, and treatment, Mayo Clin. Proc., 91 (2016), 1778-1810. https://doi.org/10.1016/j.mayocp.2016.08.022 doi: 10.1016/j.mayocp.2016.08.022
    [27] L. Staerk, J. A. Sherer, D. Ko, E. J. Benjamin, R. H. Helm, Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes, Circ. Res., 120 (2017), 1501-1517. https://doi.org/10.1161/CIRCRESAHA.117.309732 doi: 10.1161/CIRCRESAHA.117.309732
    [28] S. Nattel, Molecular and cellular mechanisms of atrial fibrosis in atrial fibrillation, JACC Clin. Electrophysiol., 3 (2017), 425-435. https://doi.org/10.1016/j.jacep.2017.03.002 doi: 10.1016/j.jacep.2017.03.002
    [29] Y. Iwasaki, K. Nishida, T. Kato, S. Nattel, Atrial fibrillation pathophysiology: implications for management, Circulation, 124 (2011), 2264-2274. https://doi.org/10.1161/CIRCULATIONAHA.111.019893 doi: 10.1161/CIRCULATIONAHA.111.019893
    [30] C. Zhang, Y. Zhang, H. Zhu, J. Hu, Z. Xie, MiR-34a/miR-93 target c-Ski to modulate the proliferaton of rat cardiac fibroblasts and extracellular matrix deposition in vivo and in vitro, Cell. Signalling, 46 (2018), 145-153. https://doi.org/10.1016/j.cellsig.2018.03.005 doi: 10.1016/j.cellsig.2018.03.005
    [31] Q. Wang, Y. Yu, P. Zhang, Y. Chen, C. Li, J. Chen, et al., The crucial role of activin A/ALK4 pathway in the pathogenesis of Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation, Basic Res. Cardiol., 112 (2017), 47. https://doi.org/10.1007/s00395-017-0634-1 doi: 10.1007/s00395-017-0634-1
    [32] B. Li, W. Shen, H. Peng, Y. Li, F. Chen, L. Zheng, et al., Fibronectin 1 promotes melanoma proliferation and metastasis by inhibiting apoptosis and regulating EMT, Onco Targets Ther., 12 (2019), 3207-3221. https://doi.org/10.2147/OTT.S195703 doi: 10.2147/OTT.S195703
    [33] H. Zhang, X. Chen, P. Xue, X. Ma, J. Li, J. Zhang, FN1 promotes chondrocyte differentiation and collagen production via TGF-beta/PI3K/Akt pathway in mice with femoral fracture, Gene, 769 (2021), 145253. https://doi.org/10.1016/j.gene.2020.145253 doi: 10.1016/j.gene.2020.145253
    [34] Y. X. Liao, Z. P. Zhang, J. Zhao, J. P. Liu, Effects of fibronectin 1 on cell proliferation, senescence and apoptosis of human glioma cells through the PI3K/AKT signaling pathway, Cell. Physiol. Biochem., 48 (2018), 1382-1396. https://doi.org/10.1159/000492096 doi: 10.1159/000492096
    [35] H. P. Ma, H. L. Chang, O. A. Bamodu, V. K. Yadav, T. Y. Huang, A. T. H. Wu, et al., Collagen 1A1 (COL1A1) is a reliable biomarker and putative therapeutic target for hepatocellular carcinogenesis and metastasis, Cancers (Basel), 11 (2019), 786. https://doi.org/10.3390/cancers11060786. doi: 10.3390/cancers11060786
    [36] K. Gelse, E. Pöschl, T. Aigner, Collagens-structure, function, and biosynthesis, Adv. Drug Delivery Rev., 55 (2003), 1531-1546. https://doi.org/10.1016/j.addr.2003.08.002 doi: 10.1016/j.addr.2003.08.002
    [37] J. Y. Exposito, U. Valcourt, C. Cluzel, C. Lethias, The fibrillar collagen family, Int. J. Mol. Sci., 11 (2010), 407-426. https://doi.org/10.3390/ijms11020407 doi: 10.3390/ijms11020407
    [38] K. T. Weber, Cardiac interstitium in health and disease: the fibrillar collagen network, J. Am. Coll. Cardiol., 13 (1989), 1637-1652. https://doi.org/10.1016/0735-1097(89)90360-4 doi: 10.1016/0735-1097(89)90360-4
    [39] J. Xu, G. Cui, F. Esmailian, M. Plunkett, D. Marelli, A. Ardehali, et al., Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation, Circulation, 109 (2004), 363-368. https://doi.org/10.1161/01.CIR.0000109495.02213.52 doi: 10.1161/01.CIR.0000109495.02213.52
    [40] A. Boldt, U. Wetzel, J. Lauschke, J. Weigl, J. Gummert, G. Hindricks, et al., Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease, Heart, 90 (2004), 400-405. https://doi.org/10.1136/hrt.2003.015347 doi: 10.1136/hrt.2003.015347
    [41] F. G. Akar, R. D. Nass, S. Hahn, E. Cingolani, M. Shah, G. G. Hesketh, et al., Dynamic changes in conduction velocity and gap junction properties during development of pacing-induced heart failure, Am. J. Physiol. Heart Circ. Physiol., 293 (2007), H1223-H1230. https://doi.org/10.1152/ajpheart.00079.2007 doi: 10.1152/ajpheart.00079.2007
    [42] C. Rucker-Martin, P. Milliez, S. Tan, X. Decrouy, M. Recouvreur, R. Vranckx, et al., Chronic hemodynamic overload of the atria is an important factor for gap junction remodeling in human and rat hearts, Cardiovasc. Res., 72 (2006), 69-79. https://doi.org/10.1016/j.cardiores.2006.06.016 doi: 10.1016/j.cardiores.2006.06.016
    [43] I. I. de Caceres, E. Dulaimi, A. M. Hoffman, T. Al-Saleem, R. G. Uzzo, P. Cairns, Identification of novel target genes by an epigenetic reactivation screen of renal cancer, Cancer Res., 66 (2006), 5021-5028. https://doi.org/10.1158/0008-5472.CAN-05-3365 doi: 10.1158/0008-5472.CAN-05-3365
    [44] V. F. Bonazzi, D. J. Nancarrow, M. S. Stark, R. J. Moser, G. M. Boyle, L. G. Aoude, et al., Cross-platform array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as genes frequently silenced by methylation in melanoma, PLoS One, 6 (2011), e26121. https://doi.org/10.1371/journal.pone.0026121 doi: 10.1371/journal.pone.0026121
    [45] X. Xue, X. Ling, W. Xi, P. Wang, J. Sun, Q. Yang, et al., Exogenous hydrogen sulfide reduces atrial remodeling and atrial fibrillation induced by diabetes mellitus via activation of the PI3K/Akt/eNOS pathway, Mol. Med. Rep., 22 (2020), 1759-1766. https://doi.org/10.3892/mmr.2020.11291 doi: 10.3892/mmr.2020.11291
    [46] J. Wang, Z. Li, J. Du, J. Li, Y. Zhang, J. Liu, et al., The expression profile analysis of atrial mRNA in rats with atrial fibrillation: the role of IGF1 in atrial fibrosis, BMC Cardiovasc. Disord., 19 (2019), 40. https://doi.org/10.1186/s12872-019-1013-7 doi: 10.1186/s12872-019-1013-7
    [47] X. Shan, Z. Liu, M. Wulasihan, S. Ma, Edoxaban improves atrial fibrillation and thromboembolism through regulation of the Wnt-beta-induced PI3K/ATK-activated protein C system, Exp. Ther. Med., 17 (2019), 3509-3517. https://doi.org/10.3892/etm.2019.7379 doi: 10.3892/etm.2019.7379
    [48] X. Liu, X. Huang, L. Chen, Y. Zhang, M. Li, L. Wang, et al. Mechanical stretch promotes matrix metalloproteinase-2 and prolyl-4-hydroxylase alpha1 production in human aortic smooth muscle cells via Akt-p38 MAPK-JNK signaling, Int. J. Biochem. Cell Biol., 62 (2015), 15-23. https://doi.org/10.1016/j.biocel.2015.02.009 doi: 10.1016/j.biocel.2015.02.009
    [49] K. I. Kivirikko, T. Pihlajaniemi, Collagen hydroxylases and the protein disulfide isomerase subunit of prolyl 4-hydroxylases, Adv. Enzymol. Relat. Areas Mol. Biol., 72 (1998), 325-398. https://doi.org/10.1002/9780470123188.ch9 doi: 10.1002/9780470123188.ch9
    [50] Q. Zhao, J. Liu, P4HA1, a prognostic biomarker that correlates with immune infiltrates in lung adenocarcinoma and pan-cancer, Front. Cell Dev. Biol., 9 (2021), 754580. https://doi.org/10.3389/fcell.2021.754580 doi: 10.3389/fcell.2021.754580
    [51] T. Zhao, H. Chen, C. Cheng, J. Zhang, Z. Yan, J. Kuang, et al., Liraglutide protects high-glucose-stimulated fibroblasts by activating the CD36-JNK-AP1 pathway to downregulate P4HA1, Biomed. Pharmacother., 118 (2019), 109224. https://doi.org/10.1016/j.biopha.2019.109224 doi: 10.1016/j.biopha.2019.109224
    [52] L. Chen, Y. H. Shen, X. Wang, J. Wang, Y. Gan, N. Chen, et al., Human prolyl-4-hydroxylase alpha(I) transcription is mediated by upstream stimulatory factors, J. Biol. Chem., 281 (2006), 10849-10855. https://doi.org/10.1074/jbc.M511237200 doi: 10.1074/jbc.M511237200
    [53] S. H. Chang, Y. H. Yeh, J. L. Lee, Y. J. Hsu, C. T. Kuo, W. J. Chen, Transforming growth factor-beta-mediated CD44/STAT3 signaling contributes to the development of atrial fibrosis and fibrillation, Basic Res. Cardiol., 112 (2017), 58. https://doi.org/10.1007/s00395-017-0647-9 doi: 10.1007/s00395-017-0647-9
    [54] J. Yang, L. Chen, J. Yang, J. Ding, S. Li, H. Wu, et al., MicroRNA-22 targeting CBP protects against myocardial ischemia-reperfusion injury through anti-apoptosis in rats, Mol. Biol. Rep., 41 (2014), 555-561. https://doi.org/10.1007/s11033-013-2891-x doi: 10.1007/s11033-013-2891-x
    [55] P. Kirchhof, E. Marijon, L. Fabritz, N. Li, W. Wang, T. Wang, et al. Overexpression of cAMP-response element modulator causes abnormal growth and development of the atrial myocardium resulting in a substrate for sustained atrial fibrillation in mice, Int. J. Cardiol., 166 (2013), 366-374. https://doi.org/10.1016/j.ijcard.2011.10.057 doi: 10.1016/j.ijcard.2011.10.057
    [56] N. Li, D. Y. Chiang, S. Wang, Q. Wang, L. Sun, N. Voigt, et al., Ryanodine receptor-mediated calcium leak drives progressive development of an atrial fibrillation substrate in a transgenic mouse model, Circulation, 129 (2014), 1276-1285. https://doi.org/10.1161/CIRCULATIONAHA.113.006611 doi: 10.1161/CIRCULATIONAHA.113.006611
    [57] S. H. Chang, Y. H. Chan, W. J. Chen, G. J. Chang, J. L. Lee, Y. H. Yeh, et al., Tachypacing-induced CREB/CD44 signaling contributes to the suppression of L-type calcium channel expression and the development of atrial remodeling, Heart Rhythm, 18 (2021), 1760-1771. https://doi.org/10.1016/j.hrthm.2021.05.021 doi: 10.1016/j.hrthm.2021.05.021
    [58] R. F. Bosch, X. Zeng, J. B. Grammer, K. Popovic, C. Mewis, V. Kühlkamp, Ionic mechanisms of electrical remodeling in human atrial fibrillation, Cardiovasc. Res., 44 (1999), 121-131. https://doi.org/10.1016/S0008-6363(99)00178-9 doi: 10.1016/S0008-6363(99)00178-9
    [59] L. Yue, P. Melnyk, R. Gaspo, Z. Wang, S. Nattel, Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation, Circ. Res., 84 (1999), 776-784. https://doi.org/10.1161/01.RES.84.7.776 doi: 10.1161/01.RES.84.7.776
    [60] X. Y. Qi, Y. H. Yeh, L. Xiao, B. Burstein, A. Maguy, D. Chartier, et al., Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current, Circ. Res., 103 (2008), 845-854. https://doi.org/10.1161/CIRCRESAHA.108.175463 doi: 10.1161/CIRCRESAHA.108.175463
  • Reader Comments
  • © 2023 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(3335) PDF downloads(161) Cited by(0)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog